BLOG
Injunctive Relief Agreement Creates Sweeping Guidance for Suspicious Order Monitoring
Injunctive Relief Agreement Creates Sweeping Guidance for Suspicious Order Monitoring Written-by: Sumeet Singh, CEO Background The Opioid Epidemic is one of the greater tragedies to occur within the last few decades and will forever be a black mark on the drug supply...
Recent Articles
Walgreen’s Boots Alliance Catches Up & Makes a Play to Get Ahead
Walgreen's Boots Alliance Catches Up & Makes a Play to Get Ahead Likely feeling pressure from recent moves by both CVS and Amazon, Walgreens...
Telehealth Growth Trajectory Continues Upward
Telehealth Growth Trajectory Continues Upward Telehealth technology presents a unique opportunity to revolutionize multiple aspects of healthcare....
Why Amazon’s Healthcare Trio Is Undeniably BRILLIANT
Why Amazon’s Healthcare Trio Is Undeniably BRILLIANT On January 30, 2018, Amazon, JP Morgan, and Berkshire Hathaway announced that they would form...
DEA Reportedly Set to Revise SORS Guidelines and (Hopefully) Clarify the Meaning of “Suspicious”
DEA Reportedly Set to Revise SORS Guidelines and (Hopefully) Clarify the Meaning of “Suspicious” As the opioid crisis continues to grow and further...
HealthWarehouse.com – The Perfect Amazon Acquisition
HealthWarehouse.com – The Perfect Amazon Acquisition Companies across the United States have been on edge over the last couple of years as Amazon...
Biggest Industry Players Face Pressure from Public and the DEA on Suspicious Order Monitoring
Biggest Industry Players Face Pressure from Public and the DEA on Suspicious Order Monitoring The Opioid Epidemic has been a devastating trend in...
